Multicorp International, Inc. (PN) Stock Price - MCIC

Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
$33.03
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Multicorp International, Inc. (PN) MCIC OTCMarkets Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 0.0011 0.00 0.00 0.00 0.0011 07:50:28
Bid Price Ask Price Spread Spread % News
0.0011 0.0015 0.0004 26.67% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.00 USD

Multicorp International, Inc. (PN) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 1.44M 1.31B - - 533.78M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
43.54k $ - 0.00% - -

more financials information »

Multicorp International, Inc. (PN) News

Loading Messages....

Latest MCIC Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MCIC Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00150.00150.00110.001243765,550-0.0004-26.67%
1 Month0.001320.00150.00110.001269194,960-0.00022-16.67%
3 Months0.00150.00180.00110.0013399255,524-0.0004-26.67%
6 Months0.00250.00250.0010.0016551331,684-0.0014-56.0%
1 Year0.0010.00250.00080.0015248327,8620.000110.0%
3 Years0.00080.00450.00050.0016801428,8570.000337.5%
5 Years0.00120.00630.00010.0016275460,722-0.0001-8.33%

Multicorp International, Inc. (PN) Description

MultiCorp International, Inc is committed itself to the further development of the patented migraine medicine the company owns a significant percentage of. The company has received information from the U.S. Food and Drug Administration that provides the company with a clear path to further the development of the drug to bring to market. The company is currently looking to partner with a pharmaceutical company that can assist the company in bringing the migraine medicine to market. For further information please contact them at info@multicorpinternational.com


Your Recent History
USOTC
MCIC
Multicorp ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.